Proteomic characterization of FBXW7-mutant CRISPR
Awarded Award Notice Posted
- Solicitation number
- 75N92019Q0180
- Agency
- National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
- Awarded
- to Cell Signaling Technology, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N92019P00334 Federal contract award
- NAICS code
- 621511 Medical Laboratories
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
Proteomic characterization of FBXW7-mutant CRISPR edited uterine cancer cells. Awarded Vendors: CELL SIGNALING TECHNOLOGY, INC.
3 TRASK LANE
DANVERS
MA
01923
USA. Contract Award Dollar Amount: $148,500.00. Contract Award Date: 2019-08-15.
Update #1 ·
Proteomic characterization of FBXW7-mutant CRISPR edited uterine cancer cells.
Attachments
| File | Type | Posted |
|---|---|---|
| FedConnect File | — |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity